‘Diagnostics Has Been Underestimated’: COVID-19 Testing Drives Roche Diagnostics Q1 Sales

 
• By Catherine Longworth

Roche's diagnostics sales increased 5% to $2.93bn in the first quarter of 2020. Molecular diagnostics was the main growth contributor, driven by demand for COVID-19 tests and automated testing systems.

Quarterly resluts on typewriter close up
• Source: shutterstock.com

More from In Vitro Diagnostics

More from Diagnostics